Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients

Mauro Gori, View ORCID ProfileCarlo Berzuini, Emilia D’Elia, Arianna Ghirardi, Luisa Bernardinelli, Antonello Gavazzi, Giulio Balestrieri, Andrea Giammarresi, Roberto Trevisan, Fabiano Di Marco, Antonio Bellasi, Mariangela Amoroso, Federico Raimondi, Luca Novelli, Bianca Magro, Gianpaolo Mangia, Ferdinando L. Lorini, Giulio Guagliumi, Stefano Fagiuoli, Gianfranco Parati, Michele Senni
doi: https://doi.org/10.1101/2020.12.15.20247999
Mauro Gori
1Cardiovascular Department, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo Berzuini
8ASST Papa Giovanni XXIII – Bergamo. From the Department of Biostatistics, School of Health Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
13The University of Manchester, Manchester M13 9PL, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlo Berzuini
Emilia D’Elia
1Cardiovascular Department, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arianna Ghirardi
5FROM Research Foundation, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luisa Bernardinelli
9Department of Brain and Behavioural Sciences, The University of Pavia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonello Gavazzi
5FROM Research Foundation, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulio Balestrieri
1Cardiovascular Department, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Giammarresi
1Cardiovascular Department, Italy
5FROM Research Foundation, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Trevisan
6Endocrinology Unit, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiano Di Marco
2Unit of Pulmonary Medicine, Italy
11Milano; University of Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Bellasi
7Department of Research, Innovation, Brand Reputation, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariangela Amoroso
2Unit of Pulmonary Medicine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federico Raimondi
2Unit of Pulmonary Medicine, Italy
11Milano; University of Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Novelli
2Unit of Pulmonary Medicine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bianca Magro
3Gastroenterology Hepatology and Transplantation Unit, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianpaolo Mangia
3Gastroenterology Hepatology and Transplantation Unit, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferdinando L. Lorini
4Intensive Care Unit, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulio Guagliumi
1Cardiovascular Department, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Fagiuoli
3Gastroenterology Hepatology and Transplantation Unit, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianfranco Parati
10From the Istituto Auxologico Italiano, IRCCS, Dept. of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital, Italy
12Milan, Department of Medicine and Surgery, University of Milan-Bicocca, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gianfranco.parati@unimib.it
Michele Senni
1Cardiovascular Department, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

From a cohort of 1352 consecutive patients admitted with coronavirus disease (Covid-19) to Papa Giovanni XXIII Hospital in Bergamo, Italy, between February and April 2020, we selected and studied 688 patients with arterial hypertension (254 deaths) to assess whether use of renin-angiotensin system inhibitors (RASIs) prior to hospital admission affects mortality from Covid-19. Prior use of RASIs was associated with a lower mortality in the over-68 group of patients, whereas no evidence of a similar effect (whether protective or adverse) was found in the younger group. There was positive relative excess due to a statistically significant (p =0.001) interaction between prior RASI exposure and an age greater than 68 years, corresponding to a positive relative excess risk. Next we used the subgroup of 411 hypertensive patients older than 68 yrs to separately assess the effects prior use of two RASI drug subclasses, angiotensin-converting enzyme inhibitors (ACEIs) and angiogiotensin receptor blockers (ARBs), by comparing these two exposures with no exposure to RASIs. We found both prior use of ACEIs and prior use of ARBs to be associated with a lower Covid-19 mortality, after adjusting for 32 medical history variables via propensity score matching. (ORACEI = 0.57, 95%CI 0.36 to 0.91, p =0.018) (ORARB = 0.49, 95%CI 0.29 to 0.82, p =0.006).

Competing Interest Statement

MG: consulting fees from Novartis, Boehringer, and Menarini RT: received lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, and Sanofi, and has participated in advisory panels for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, and Sanofi. SF: speaker's bureau and advisory board for Gilead, Abbvie, MSD, Novartis, Astellas, Intercept, Kedrion, Bayer. MS: Bayer, Novartis, Boehringer, Astrazeneca. REMAINING AUTHORS: none

Funding Statement

No funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NECESSARY APPROVAL was obtained from the Bergamo Ethics Committee (n. 37/2020) with operating center at the Papa Giovanni XXIII Hospital of Bergamo, which has capacity to give its opinion on studies conducted in a number of health care structures in the Bergamo area of the north-italian region Lombardia, including the mentioned hospital, plus ten Aziende Socio Sanitarie Territoriali and fourteen Agenzie di Tutela della Salute. In conformity with local protocol, consent was obtained from the patient.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data may be requested to the Research Foundation of Bergamo Hospital, Bergamo, Italy (CovidLab)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients
Mauro Gori, Carlo Berzuini, Emilia D’Elia, Arianna Ghirardi, Luisa Bernardinelli, Antonello Gavazzi, Giulio Balestrieri, Andrea Giammarresi, Roberto Trevisan, Fabiano Di Marco, Antonio Bellasi, Mariangela Amoroso, Federico Raimondi, Luca Novelli, Bianca Magro, Gianpaolo Mangia, Ferdinando L. Lorini, Giulio Guagliumi, Stefano Fagiuoli, Gianfranco Parati, Michele Senni
medRxiv 2020.12.15.20247999; doi: https://doi.org/10.1101/2020.12.15.20247999
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients
Mauro Gori, Carlo Berzuini, Emilia D’Elia, Arianna Ghirardi, Luisa Bernardinelli, Antonello Gavazzi, Giulio Balestrieri, Andrea Giammarresi, Roberto Trevisan, Fabiano Di Marco, Antonio Bellasi, Mariangela Amoroso, Federico Raimondi, Luca Novelli, Bianca Magro, Gianpaolo Mangia, Ferdinando L. Lorini, Giulio Guagliumi, Stefano Fagiuoli, Gianfranco Parati, Michele Senni
medRxiv 2020.12.15.20247999; doi: https://doi.org/10.1101/2020.12.15.20247999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (454)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5288)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (701)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5922)
  • Intensive Care and Critical Care Medicine (366)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (133)
  • Obstetrics and Gynecology (145)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (137)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2033)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)